Research

Effectiveness of a pharmacist-driven intervention in COPD (EPIC2): a randomized trial

Primary Investigators: Drs John Hawboldt and Erin Davis
Funded by: Health Research Foundation (Canada)
Anticipated timeline: March 2017 to May 2019

Project overview

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that cause breathing difficulties. Patients with lung disease often do not take their medications as prescribed (non-adherent) and can have poor inhaler technique. Community pharmacists may be able to improve patient medication adherence thus raising quality of life, reducing complications and reducing healthcare resource use and cost. The aim of this study is to measure the effect of meeting with a pharmacist at the MTS clinic on patients with COPD. The methods and results from this study could be used to improve the care provided by community pharmacists in the real world. This would improve the health and quality of life of patients with COPD.

For more information visit this link

Impact of a Pharmacist-Administered Deprescribing Intervention on Nursing Home Residents: A Randomized Controlled Trial

Primary Investigators: Drs Debbie Kelly and Cathy Balsom
Funded by: NL SUPPORT Allied Health Professional Led Research Grant
Anticipated timeline: February 2017 to Sept 2018

Project overview

Commonly, aging is accompanied by an increased number of health conditions and medications. With increased medication use comes an increased risk of side effects and interactions. This study will carry out in depth medication reviews of residents of St. Patrick's Mercy Home -- a long term care facility - with the aim of reducing the number of unnecessary or inappropriate medications.

For more information visit this link

Optimizing Medication Therapy Outcomes for High Risk Patients Transitioning from Acute to Primary Care

Primary Investigator: Dr. Debbie Kelly
Funded by: NL SUPPORT Patient Oriented Research Grant
Anticipated timeline: December 2016 to December 2018

Project overview

Patients who are discharged from hospital can be overwhelmed when they suddenly have to manage new conditions or medications. These changes can be particularly difficult for people on many medications or with multiple health conditions. There is a real risk that this will lead to emergency room visits, or hospital readmission shortly after discharge. This project will determine if a pharmacist-led medication therapy management service can improve health outcomes of 'medically complex' patients transitioning from acute to primary care in Newfoundland and Labrador.

For more information visit this link

Efficacy and Cost-Effectiveness of an Intensive and Abbreviated Individualized Smoking Cessation Support Program Delivered by Pharmacists: A Randomized Controlled Trial

Primary Investigators: Drs. Leslie Phillips and Terri Genge
Funded by: Department of Children Seniors and Social Development and NL SUPPORT Allied Health Professional Led Research Grant
Anticipated timeline: August 2018 to August 2019

Project Overview

Tobacco smoking is the leading cause of preventable disease, disability and death in Canada, resulting in approximately 40,000 premature deaths per year. Furthermore, Newfoundland and Labrador has the highest provincial smoking rate. In an effort to address the current tobacco use epidemic, an individualized smoking cessation program was developed and offered to interested participants at the MTS Clinic. This project aims to evaluate this program with the hope it can be offered at community pharmacies province wide.

Contact

School of Pharmacy

230 Elizabeth Ave, St. John's, NL, CANADA, A1B 3X9

Postal Address: P.O. Box 4200, St. John's, NL, CANADA, A1C 5S7

Tel: (709) 864-8000